
Company studio and early-stage investor that designs, builds and funds startups with hands-on founder support

Early growth equity investor in fast-scaling B2B software and healthcare companies

Noro-Moseley Partners, based in Atlanta, Georgia, puts early growth equity into rapidly scaling B2B software and healthcare companies. The firm says it has partnered with exceptional teams since 1983. It describes itself as partnering with strong CEOs of high-growth businesses, and it says that together they scale. The firm reports exits since 2015 across its portfolio.
The firm invests in businesses that meet specific criteria: a target revenue run rate within a defined range, a significant opportunity for market disruption and minimal prior funding. It says it is actively investing in companies that meet these criteria, and that it looks for businesses able to use a strong position to change the market they serve.
Several portfolio companies show the firm's focus. Red Canary delivers managed detection and response across the enterprise, so that security teams can concentrate on the most serious issues rather than building their own threat detection operation; it was acquired by Zscaler in 2025. Elligo automates access to patient data for decentralized clinical trials and says its platform has been used in more than 200 trials. MacStadium provides enterprise cloud infrastructure for Mac and iOS app development, running a large fleet of Mac machines across data centers.
Findhelp runs what its material calls the largest social services search and referral network in the US, covering programs in every zip code for everything from food and housing assistance to healthcare. Upward Health, a care management business, was selected by a San Francisco health plan for an enhanced care management initiative and was awarded a contract under the ACO REACH model by CMS. LogicStream Health has worked with FDB to help manage drug shortages. Medix Infusion raised a Series B led by Echo Health Ventures, and Revenue Analytics received a strategic growth investment from Lead Edge Capital.
Recent portfolio news includes Trilliant Health launching an AI strategist that answers questions about healthcare, Brinqa acquiring PlexTrac to close a loop in exposure management, and EAIGLE securing growth funding from Noro-Moseley and In Revenue Capital to scale AI-native gate and yard automation.
Noro-Moseley Partners is a venture firm that provides early growth equity. It works with rapidly scaling business software and healthcare companies and has been investing since 1983.
B2B software and healthcare companies with minimal prior funding and a significant chance to disrupt their market. Portfolio names on its site include Red Canary, Elligo, MacStadium and Findhelp.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Noro-Moseley Partners.
Similar listings buyers compare against this one.

Company studio and early-stage investor that designs, builds and funds startups with hands-on founder support

Medical device manufacturer making implants and therapies for heart, cancer and spinal conditions

Global startup accelerator and early-stage investor running city and sector programmes for founders

Silicon Valley venture capital firm that has backed well-known technology companies since their early stages

Innovation platform running accelerator programmes and startup investments that link corporations with young technology companies

Global software investor backing growth-stage technology companies with capital and in-house operating specialists

A Tel Aviv-based investment group backing technology and healthcare companies

Vancouver venture capital firm funding early-stage technology and consumer product companies
Everything here links back to the same verified catalogue. Pick your next stop.